tech:

taffy

Jelly Raises Series B Round

Social search app Jelly has raised an unspecified Series B round from Greylock Partners. Spark Capital also participated in the round.

The company had previously raised a Series A round in May last year. Jelly investors include Jack Dorsey, Bono, Reid Hoffman, Steven Johnson, Evan Williams, Jason Goldman, Al Gore, Greg Yaitanes, and Roya Mahboob.

Jelly lets users submit questions, which is then submitted to people in their network who also have Jelly. Users can also upload pictures as part of the question. Jelly notifies users when they have answers.

[Image courtesy: Jelly]

Also see:

Just in

Apple sued in a landmark iPhone monopoly lawsuit — CNN

The US Justice Department and more than a dozen states filed a blockbuster antitrust lawsuit against Apple on Thursday, accusing the giant company of illegally monopolizing the smartphone market, writes Brian Fung, Hannah Rabinowitz and Evan Perez.

Google is bringing satellite messaging to Android 15 — The Verge

Google’s second developer preview for Android 15 has arrived, bringing long-awaited support for satellite connectivity alongside several improvements to contactless payments, multi-language recognition, volume consistency, and interaction with PDFs via apps, writes Jess Weatherbed. 

Reddit CEO Steve Huffman is paid more than the heads of Meta, Pinterest, and Snap — combined — QZ

Reddit co-founder and CEO Steve Huffman has been blasted by Redditors and in media reports over his recently-revealed, super-sized pay package of $193 million in 2023, writes Laura Bratton. 

British AI pioneer Mustafa Suleyman joins Microsoft — BBC

Microsoft has announced British Artificial Intelligence pioneer Mustafa Suleyman will lead its newly-formed division, Microsoft AI, according to the BBC report. 

UnitedHealth Group has paid more than $2 billion to providers following cyberattack — CNBC

UnitedHealth Group said Monday that it’s paid out more than $2 billion to help health-care providers who have been affected by the cyberattack on subsidiary Change Healthcare, writes Ashley Capoot.